Research graph
References from Surface charge-dependent effects of BSA-curcumin nanoparticles combined with amikacin in antimicrobial photodynamic therapy: A pilot In Vivo study of multidrug-resistant Pseudomonas aeruginosa skin infection. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3390/ijms25010037
10.3390/ijms25010037 · 2024 · External reference
10.1155/2022/5344085
10.1155/2022/5344085 · 2022 · External reference
10.3390/w15183200
10.3390/w15183200 · 2023 · External reference
10.1016/j.ejpb.2021.01.012
10.1016/j.ejpb.2021.01.012 · 2021 · External reference
10.1016/j.pdpdt.2024.103971
10.1016/j.pdpdt.2024.103971 · 2024 · External reference
10.1016/j.copbio.2024.103128
10.1016/j.copbio.2024.103128 · 2024 · External reference
10.1002/advs.202402935
10.1002/advs.202402935 · 2024 · External reference
10.1128/aac.01991-21
10.1128/aac.01991-21 · 2022 · External reference
10.1039/d2fo03929j
10.1039/d2fo03929j · 2023 · External reference
10.1016/j.biopha.2025.118360
10.1016/j.biopha.2025.118360 · 2025 · External reference
10.25110/arqsaude.v26i3.2022.8851
10.25110/arqsaude.v26i3.2022.8851 · 2022 · External reference
10.1128/cmr.00181-19
10.1128/cmr.00181-19 · 2020 · External reference
10.3390/ijms23063226
10.3390/ijms23063226 · 2022 · External reference
10.3390/antibiotics10111429
10.3390/antibiotics10111429 · 2021 · External reference
10.1016/j.mib.2016.06.008
10.1016/j.mib.2016.06.008 · 2016 · External reference
10.1016/j.mtadv.2025.100633
10.1016/j.mtadv.2025.100633 · 2025 · External reference
10.21270/archi.v10i1.5013
10.21270/archi.v10i1.5013 · 2021 · External reference
10.3390/pharmaceutics15020639
10.3390/pharmaceutics15020639 · 2023 · External reference
10.1021/acsomega.3c00110
10.1021/acsomega.3c00110 · 2023 · External reference
10.1016/j.addr.2022.114635
10.1016/j.addr.2022.114635 · 2023 · External reference
10.1016/j.nano.2014.09.004
10.1016/j.nano.2014.09.004 · 2015 · External reference
10.3389/fchem.2022.969809
10.3389/fchem.2022.969809 · 2022 · External reference
10.1007/s00018-016-2268-0
10.1007/s00018-016-2268-0 · 2016 · External reference
10.1016/j.pdpdt.2024.104001
10.1016/j.pdpdt.2024.104001 · 2024 · External reference
10.3390/pathogens15020226
10.3390/pathogens15020226 · 2026 · External reference
10.1016/j.ijpharm.2024.123947
10.1016/j.ijpharm.2024.123947 · 2024 · External reference
10.1038/s41579-024-01054-w
10.1038/s41579-024-01054-w · 2024 · External reference
10.1016/j.pdpdt.2019.101639
10.1016/j.pdpdt.2019.101639 · 2020 · External reference
10.1016/j.heliyon.2023.e13740
10.1016/j.heliyon.2023.e13740 · 2023 · External reference
10.1039/c4cs00487f
10.1039/c4cs00487f · 2015 · External reference
10.3389/fbioe.2023.1243651
10.3389/fbioe.2023.1243651 · 2023 · External reference
10.1016/j.mtbio.2025.101470
10.1016/j.mtbio.2025.101470 · 2025 · External reference
10.3390/antibiotics10040401
10.3390/antibiotics10040401 · 2021 · External reference
10.1039/d4nj01576b
10.1039/d4nj01576b · 2024 · External reference
10.1186/s12866-022-02438-9
10.1186/s12866-022-02438-9 · 2022 · External reference
10.3390/pharmaceutics16010117
10.3390/pharmaceutics16010117 · 2024 · External reference
10.1166/mex.2020.1861
10.1166/mex.2020.1861 · 2020 · External reference
10.1152/physrev.00067.2017
10.1152/physrev.00067.2017 · 2019 · External reference
10.3390/ph18040470
10.3390/ph18040470 · 2025 · External reference
Unresolved reference
External reference
10.1021/acsami.2c22471
10.1021/acsami.2c22471 · 2023 · External reference
10.1039/d0cs01370f
10.1039/d0cs01370f · 2021 · External reference
10.1016/j.bioadv.2024.213820
10.1016/j.bioadv.2024.213820 · 2024 · External reference
10.3389/fcell.2020.585132
10.3389/fcell.2020.585132 · 2020 · External reference
10.3389/fmicb.2022.876166
10.3389/fmicb.2022.876166 · 2022 · External reference
10.3390/antibiotics13121111
10.3390/antibiotics13121111 · 2024 · External reference
10.1186/s40364-026-00935-x
10.1186/s40364-026-00935-x · 2026 · External reference
